BiotechTube
Home/PathCision Medicine/Ling Cheng
LC

Ling Cheng

CTO, Head of AI

PathCision Medicine

Therapeutic Areas

Oncology

PathCision Medicine Pipeline

DrugIndicationPhase
UndisclosedOncology (starting with metastatic cancer)Preclinical

Leadership Team at PathCision Medicine

SW
Shana Wang
CEO & Co-Founder
DL
David Lee, M.D., Ph.D.
CSO & Co-Founder
View full PathCision Medicine profile